Prostate cancer continues to pose substantial clinical challenges, with increasing incidence and mortality rates in the United States. While PSMA-directed radioligand therapy (RLT) and advanced imaging technologies have transformed the diagnosis and treatment of metastatic prostate cancer, knowledge gaps persist regarding optimal use, patient selection, sequencing, and integration into multidisciplinary care. Additionally, disparities in access and implementation across care settings underscore the urgent need for clinician education.

To address these unmet needs, PER® has developed this online activity that features four concise modules with expert video interviews. Topics will span PSMA imaging interpretation, the science and clinical application of RLT, patient selection and toxicity management, and strategies to expand equitable access through multidisciplinary care.

Click Here to Download Fillable Discussion Guide

Click Here to Download Cancer Insight Summary Slides